Folgen
Nassos Typas
Nassos Typas
Group Leader, EMBL
Bestätigte E-Mail-Adresse bei embl.de - Startseite
Titel
Zitiert von
Zitiert von
Jahr
Extensive impact of non-antibiotic drugs on human gut bacteria
L Maier, M Pruteanu, M Kuhn, G Zeller, A Telzerow, EE Anderson, ...
Nature 555 (7698), 623-628, 2018
18162018
From the regulation of peptidoglycan synthesis to bacterial growth and morphology
A Typas, M Banzhaf, CA Gross, W Vollmer
Nature Reviews Microbiology 10 (2), 123-136, 2012
14342012
Salt-responsive gut commensal modulates TH17 axis and disease
N Wilck, MG Matus, SM Kearney, SW Olesen, K Forslund, ...
Nature 551 (7682), 585-589, 2017
12152017
Phenotypic landscape of a bacterial cell
RJ Nichols, S Sen, YJ Choo, P Beltrao, M Zietek, R Chaba, S Lee, ...
Cell 144 (1), 143-156, 2011
7842011
Recovery of gut microbiota of healthy adults following antibiotic exposure
A Palleja, KH Mikkelsen, SK Forslund, A Kashani, KH Allin, T Nielsen, ...
Nature microbiology 3 (11), 1255-1265, 2018
6862018
A new antibiotic selectively kills Gram-negative pathogens
Y Imai, KJ Meyer, A Iinishi, Q Favre-Godal, R Green, S Manuse, M Caboni, ...
Nature 576 (7787), 459-464, 2019
6482019
Construction and analysis of two genome-scale deletion libraries for Bacillus subtilis
BM Koo, G Kritikos, JD Farelli, H Todor, K Tong, H Kimsey, I Wapinski, ...
Cell systems 4 (3), 291-305. e7, 2017
5672017
Selective ribosome profiling reveals the cotranslational chaperone action of trigger factor in vivo
E Oh, AH Becker, A Sandikci, D Huber, R Chaba, F Gloge, RJ Nichols, ...
Cell 147 (6), 1295-1308, 2011
5222011
Country-specific antibiotic use practices impact the human gut resistome
K Forslund, S Sunagawa, JR Kultima, DR Mende, M Arumugam, A Typas, ...
Genome research 23 (7), 1163-1169, 2013
4592013
Regulation of peptidoglycan synthesis by outer-membrane proteins
A Typas, M Banzhaf, BB van Saparoea, J Verheul, J Biboy, RJ Nichols, ...
Cell 143 (7), 1097-1109, 2010
4242010
Species-specific activity of antibacterial drug combinations
AR Brochado, A Telzerow, J Bobonis, M Banzhaf, A Mateus, J Selkrig, ...
Nature 559 (7713), 259-263, 2018
3452018
Yeast creates a niche for symbiotic lactic acid bacteria through nitrogen overflow
O Ponomarova, N Gabrielli, DC Sévin, M Mülleder, K Zirngibl, K Bulyha, ...
Cell systems 5 (4), 345-357. e6, 2017
3262017
High-throughput, quantitative analyses of genetic interactions in E. coli
A Typas, RJ Nichols, DA Siegele, M Shales, SR Collins, B Lim, H Braberg, ...
Nature methods 5 (9), 781-787, 2008
2972008
Emerging and evolving concepts in gene essentiality
G Rancati, J Moffat, A Typas, N Pavelka
Nature Reviews Genetics 19 (1), 34-49, 2018
2772018
A dual-mechanism antibiotic kills gram-negative bacteria and avoids drug resistance
JK Martin, JP Sheehan, BP Bratton, GM Moore, A Mateus, SHJ Li, H Kim, ...
Cell 181 (7), 1518-1532. e14, 2020
2672020
Unravelling the collateral damage of antibiotics on gut bacteria
L Maier, CV Goemans, J Wirbel, M Kuhn, C Eberl, M Pruteanu, P Müller, ...
Nature 599 (7883), 120-124, 2021
2622021
Nutritional preferences of human gut bacteria reveal their metabolic idiosyncrasies
M Tramontano, S Andrejev, M Pruteanu, M Klünemann, M Kuhn, ...
Nature microbiology 3 (4), 514-522, 2018
2572018
Host-microbe co-metabolism dictates cancer drug efficacy in C. elegans
TA Scott, LM Quintaneiro, P Norvaisas, PP Lui, MP Wilson, KY Leung, ...
Cell 169 (3), 442-456. e18, 2017
2552017
Fe-S cluster biosynthesis controls uptake of aminoglycosides in a ROS-less death pathway
B Ezraty, A Vergnes, M Banzhaf, Y Duverger, A Huguenot, AR Brochado, ...
Science 340 (6140), 1583-1587, 2013
2442013
Bioaccumulation of therapeutic drugs by human gut bacteria
M Klünemann, S Andrejev, S Blasche, A Mateus, P Phapale, ...
Nature 597 (7877), 533-538, 2021
2342021
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20